Platelets (Nov 2022)

The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume

  • David Connor,
  • David Rabbolini,
  • Marie-Christine Morel-Kopp,
  • Kate Fixter,
  • Dea Donikian,
  • Mayuku Kondo,
  • Onki Chan,
  • Susan Jarvis,
  • Walter Chen,
  • Timothy Brighton,
  • Vivien Chen,
  • Christopher Ward,
  • Joanne Joseph

DOI
https://doi.org/10.1080/09537104.2022.2052035
Journal volume & issue
Vol. 33, no. 8
pp. 1139 – 1145

Abstract

Read online

The use of mean platelet diameter (MPD) to classify inherited thrombocytopenia (IT) has been demonstrated in several studies. Alternatively, the mean platelet volume (MPV) may be used, but in macrothrombocytopenia this may not be available. We hypothesized that platelet forward scatter (FSC) measurements using flow cytometry may be used for the size-based classification of IT. The study aimed to assess the ability of platelet FSC to measure platelet size and whether it could be used as an alternative to the MPD or MPV. Blood samples were obtained from individuals undergoing investigation for inherited platelet function disorders (IPFD, n = 40) or platelet number disorders (IPND, n = 46). A hematology analyzer was used to obtain MPV and platelet counts, flow cytometry to measure platelet FSC and ImageJ software to measure MPD from stained blood smears. The International Society of Thrombosis and Hemostasis (ISTH) Bleeding Assessment Tool (BAT) was used to calculate bleeding scores. Twenty-nine(63%) of IPND patients had an MPV that could not be reported. A significant correlation to platelet FSC was found to the MPD (p < .0001) and MPV (p < .0001) and an inverse correlation with platelet count (p < .0001). No significant correlation was found between FSC and bleeding history. In conclusion, platelet FSC is an alternative to MPV and may be used in macrothrombocytopenia where the MPV is not recorded

Keywords